Far away from the frontlines of the Ebola outbreaks in Sierra Leone, Guinea, and Liberia, where people and their caretakers die from the disease, new forms of humanitarian aid and global health financing are being leveraged behind closed doors.
In Washington, D.C., London, and Geneva, long-standing government-to-government models of global cooperation and international development assistance, imperfect as they are, are being supplanted by new forms of finance that prioritize profits for private shareholders.
